109 related articles for article (PubMed ID: 27630331)
1. Prediction of KRAS Mutation in Rectal Cancer Using MRI.
Shin YR; Kim KA; Im S; Hwang SS; Kim K
Anticancer Res; 2016 Sep; 36(9):4799-804. PubMed ID: 27630331
[TBL] [Abstract][Full Text] [Related]
2. Characterizing MRI features of rectal cancers with different KRAS status.
Xu Y; Xu Q; Ma Y; Duan J; Zhang H; Liu T; Li L; Sun H; Shi K; Xie S; Wang W
BMC Cancer; 2019 Nov; 19(1):1111. PubMed ID: 31727020
[TBL] [Abstract][Full Text] [Related]
3. Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer.
Martellucci J; Alemanno G; Castiglione F; Bergamini C; Valeri A
Updates Surg; 2015 Mar; 67(1):47-53. PubMed ID: 25702261
[TBL] [Abstract][Full Text] [Related]
4. [Comparative Evaluation of the Value of Quantitative Parameters of Dual-energy CT and MRI for KRAS Mutation in Rectal Cancer].
Lin XQ; Han T; Jing MY; Deng LN; Zhang B; Zhou JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):606-613. PubMed ID: 36065693
[TBL] [Abstract][Full Text] [Related]
5. KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
Sideris M; Moorhead J; Diaz-Cano S; Bjarnason I; Haji A; Papagrigoriadis S
Anticancer Res; 2016 Oct; 36(10):5315-5324. PubMed ID: 27798894
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer.
Guo XF; Yang WQ; Yang Q; Yuan ZL; Liu YL; Niu XH; Xu HB
Curr Med Sci; 2020 Dec; 40(6):1156-1160. PubMed ID: 33428144
[TBL] [Abstract][Full Text] [Related]
7.
Sideris M; Moorhead J; Diaz-Cano S; Haji A; Papagrigoriadis S
Anticancer Res; 2017 Mar; 37(3):1349-1357. PubMed ID: 28314302
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of KRAS Mutation Status in Rectal Cancer.
Jo P; König A; Schirmer M; Kitz J; Conradi LC; Azizian A; Bernhardt M; Wolff HA; Grade M; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
PLoS One; 2016; 11(4):e0153278. PubMed ID: 27064574
[TBL] [Abstract][Full Text] [Related]
9. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer.
Oh JE; Kim MJ; Lee J; Hur BY; Kim B; Kim DY; Baek JY; Chang HJ; Park SC; Oh JH; Cho SA; Sohn DK
Cancer Res Treat; 2020 Jan; 52(1):51-59. PubMed ID: 31096736
[TBL] [Abstract][Full Text] [Related]
10. A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer.
Liu H; Yin H; Li J; Dong X; Zheng H; Zhang T; Yin Q; Zhang Z; Lu M; Zhang H; Wang D
J Magn Reson Imaging; 2022 Dec; 56(6):1659-1668. PubMed ID: 35587946
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
12. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
Gao J; Sun ZW; Li YY; Shen L
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
[TBL] [Abstract][Full Text] [Related]
13. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
[TBL] [Abstract][Full Text] [Related]
14. Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics.
Krajnović M; Marković B; Knežević-Ušaj S; Nikolić I; Stanojević M; Nikolić V; Šiljić M; Jovanović Ćupić S; Dimitrijević B
Pathol Res Pract; 2016 Jul; 212(7):598-603. PubMed ID: 27184911
[TBL] [Abstract][Full Text] [Related]
15. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
Jo P; Bernhardt M; Nietert M; König A; Azizian A; Schirmer MA; Grade M; Kitz J; Reuter-Jessen K; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
PLoS One; 2020; 15(10):e0239806. PubMed ID: 33002027
[TBL] [Abstract][Full Text] [Related]
16. PIK3CA mutations predict local recurrences in rectal cancer patients.
He Y; Van't Veer LJ; Mikolajewska-Hanclich I; van Velthuysen ML; Zeestraten EC; Nagtegaal ID; van de Velde CJ; Marijnen CA
Clin Cancer Res; 2009 Nov; 15(22):6956-62. PubMed ID: 19903786
[TBL] [Abstract][Full Text] [Related]
17. Editorial for "A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Prediction of KRAS Mutation in Rectal Cancer".
Fernandes MC; Horvat N
J Magn Reson Imaging; 2022 Dec; 56(6):1669-1670. PubMed ID: 35575434
[No Abstract] [Full Text] [Related]
18. Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection.
Liang JT; Cheng YM; Chang KJ; Chien CT; Hsu HC
Hepatogastroenterology; 1999; 46(26):830-7. PubMed ID: 10370622
[TBL] [Abstract][Full Text] [Related]
19. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
[TBL] [Abstract][Full Text] [Related]
20. EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study.
Fernández-Esparrach G; Ayuso-Colella JR; Sendino O; Pagés M; Cuatrecasas M; Pellisé M; Maurel J; Ayuso-Colella C; González-Suárez B; Llach J; Castells A; Ginès A
Gastrointest Endosc; 2011 Aug; 74(2):347-54. PubMed ID: 21802588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
